Singapore's Parkway Pantai Sees Luxury Hospital Opportunities In China
This article was originally published in PharmAsia News
SINGAPORE - Parkway Pantai Ltd. CEO Tan See Leng has set his sights on ambitious expansion beyond the company's primary markets in Singapore and Malaysia, including a luxury hospital in China that he equates to the hotel chain Shangri-La Hotels
You may also be interested in...
United Family Healthcare’s David Rutstein On Developing China’s Private Health Sector: An Interview With PharmAsia News (Part 2 of 2)
The vice president for Medical Affairs discusses the recent Chindex Internationa merger, the challenges and opportunities that the company faces to meet the need for more private health care, as the central government ramps up spending and attitudes toward health insurance and medical incentives change.
SHANGHAI - China's prescription drugs market has seen a slowdown in growth in large cities due to implementation of government pilot reimbursement projects that could be adopted nationwide, according to a Sept. 27 Citi report
SHANGHAI - China's capital Beijing and Zhejiang Province recently issued long-awaited guidelines to encourage private investment in medical institutions, which is viewed by analysts as a signal that China will implement the policy nationwide and open the gates for private hospitals